Viruses in human oral cancers

Journal of Experimental and Clinical Cancer Research

Volumn 17, Issue 1, 1998, Pages 27-31

  Vasudevan, D M ^a   Vijayakumar, T ^b  

^a KASTURBA MEDICAL COLLEGE   (India)

^b General Hospital Trivandrum   (India)

Author keywords

Head and neck cancer; HHV 6; HPV; HSV; Oral cancer; Viruses

Indexed keywords

ARTICLE; CANCER RISK; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN TISSUE; MOUTH CANCER; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; WART VIRUS;

ADENOVIRIDAE INFECTIONS; ADENOVIRUSES, HUMAN; HEPATITIS B; HEPATITIS B VIRUS; HERPES LABIALIS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SIMPLEXVIRUS; TUMOR VIRUS INFECTIONS;

EID: 0031966454     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Padmanabhan T.K. and Vasudevan D.M.: A statistiacal analysis of cancers registered at the Regional Cancer Centre, Trivandrum, during 1977 to 1980. Ind.J.Cancer 19: 189-196, 1982.
2. Jussawalla D.J., and Deshpande V.A.: Evaluation of cancer risk in tobacco chewers and smokers; an epidemiologic assessment. Cancer 28: 244-252, 1971.
3. Vijayakumar T., and Remani P: Viruses in human oral cancer. J. Odentol. Stomatol. Maxillofac. Surg. 1: 7-11, 1989.
4. Anderson A.M., Forsby N., Klein G., Henle W., and Bjerklund A.: Relationship between the EBV genome and nasopha-ryngeal carcinoma in Caucasian patients. Int. J. Cancer 23: 762-767, 1979.
5. Klein G., and Klein E.: The changing faces of EBV research. Proc. Med. Virol. 30: 87-106, 1984.
6. Zech L., Haglund U., Nilsson K., and Klein G.: Characteristic chromosomal abnormalities in biopsies and lymphoid cell lines from patients with Burkitt and non-Burkitt lymphomas: Int. J. Cancer 17: 47-56, 1976.
7. Rawls W.E., Adam E., and Melnick J.L.: An analysis of seroepidemiological studies of herpes virus type 2 and carcinoma of the cervix. Cancer Res. 33: 1477-1482, 1973.
8. Kumari T.V., Shanmugham J., Prabha B., and Vasu-devan D.M.: Prevalence of antibodies against Herpes Simplex and Adenovirus in patients with cervical and oral cancer, a preliminary report. Ind. J. Med. Res. 75: 590-592, 1982.
9. Munoz N., Kato I., Bosch F.X., de Sanjose S., Sundquist V.A., Izarzugaza I., Gonzalez L.C., Tafur L., Gili M., and Viladiu P.: Cervical cancer and HSV type 2, case control studies in Spain and Columbia, with special reference to IgG subclasses. Int. J. Cancer 60: 438-442, 1995.
10. Hollinshead A.C., Lee O., Cheretien F.B., Tarpley J.L., Rawis W.E., and Adam E: Antibodies to herpes virus non-virion anti-gens in squamous carcinomas. Science 182: 713-715, 1973.
11. Rapp F.: Herpes virus and cancer. Adv. Cancer Res. 19: 265-302, 1974.
12. Sabin A.B., and Tarro G: Herpes simplex and herpes genitalis virus in etiology of some human cancers. Proc. Natl. Acad. Sci. (USA). 70: 3225-3229, 1973.
13. Shillitoe E.J., Greenspan D., Greenspan J.S., Hansen S., and Silverman S. Jr.: Neutralizing antibody to herpes simplex virus type 1 in patients with oral cancer. Cancer 49: 2315-2320, 1982.
14. Sabin A.B.: Herpes simplex virus non-virion antigen and their implication in certain human cancers; unconformed. Proc. Natl. Acad. Sci. (USA). 71: 3248-3252, 1974.
15. Park N.H., Dokko H., Li S.I., and Cherrick H.M.: Synergism of herpes simplex virus and tobacco specific N-nitro-samines in cell transformation. J. Oral Maxillofac. Surg. 49, 276-281, 1991.
16. Oh J.S., Park D.L., Christensen R., Akoto-Amanfu E., Kim K., and Park N.H.: Herpes simplex virus enhances the DMBA induced carcinogenesis and amplification and over expression of c-erb-B-1 proto-oncogene in hamster buccal pouch epithelium. Oral Surg. Oral Med. Oral Pathol. 68: 428-435, 1989.
17. Hwang C.B.C., and Shillitoe E.J.: DNA sequence of mutations induced in cells by herpes simplex virus type-1. Virology 78: 180-188, 1990.
18. Vijayakumar T., Shanavas K.R. and Vasudevan D.M.: Association of certain viruses and oral and cervical cancers. Brit. J. Radiol., 67 (suppl), 57-58, 1994.
19. Kumari T.V., Thankamoni H., Prabha B., Sasidharan V.K., and Vasudevan D.M.: Detection of antibodies against herpes simplex virus in patients with oral cancers. Ind. J. Cancer 21: 137-140, 1985.
20. Shillitoe E.J., Tarro G., and Lehner T.: Cell mediated immunity to herpes simplex virus type 1 and 2 antigens in leukoplakia and carcinoma in man. Oncology 33: 192-195, 1976.
21. Shillitoe E.J., Greenspan D., Greenspan J.S. and Silverman S. Jr.: Antibody to early and late antigens of herpes simplex type 1 in patients with oral cancer. Cancer 54: 266-273, 1984.
22. Kumari T.V., Vasudevan D.M., Ankathil R., Remani P., and Vijayakumar T.: Demonstration of HSV-1 antigen in patients with oral cancer by immunfluorescence and immunoperoxidase techniques. J. Exp. Pathol. 3: 75-86, 1987.
23. Larson P.A., Edstron S., Westin T., Nordkvist A., Hirch J.M. and Vahlne A.: Reactivity against herpes simplex virus in patients with head and neck cancer. Int. J. Cancer 49: 14-18, 1991.
24. Scully C., Eglin R.P., Mc Gregor A., and Ward B.P.: Oral cancer, detection of RNA complementary to herpes simplex DNA. J. Dent. Res. 61: 548-549, 1982.
25. Vasudevan D.M., Raghunath P.N., Shanavas K.R., Vijayakumar T., and Antony A.: Detection of HSV-1 DNA segments in human oral cancer biopsies by dot-blot and in-situ hybridisation techniques. J. Exp. Clin. Cancer Res. 10: 291-294, 1991.
26. Maden C., Beckmann A.M. Thomas D.B., McKnight B., Sherman K.J., and Ashley R.L.: Human pappilloma viruses, herpes simplex viruses and the risk of oral cancer in men. Am. J. Epidemiol. 135: 1093-1102, 1992.
27. Maupas P., Werner B., Larouze B., Millman I., London W.T., O'Connell A., and Blumberg B.S.: Antibody to hepatitis B core antigen in patients with primary hepatic carcinoma. Lancet 2: 9-11, 1975.
28. Vijayakumar T., Sasidharan V.K., Ankathil R., Remani P., Kumari T.V., and Vasudevan D.M.: Incidence of hepatitis B surface antigen (HBsAg) in oral cancer and carcinoma of uterine cervix. Ind. J. Cancer 21: 7-10, 1984.
29. Singh G.J., Subbarao M.V., and Rajvansha V.S.: Neutralising antibodies to adenovirus in patients with carcinoma of oral cavity and in control individuals. Ind. J. Med. Res. 62: 254-257, 1974.
30. Rangan S.R.S., Mukherjee A.L., and Bang B.: Search for an adenovirus aetiology for human oral and pharyngeal tumours. Ind. J. Cancer 4: 819-828, 1968.
31. Talacko A.A., Teo C.G., Griffin B.E., and Johnson N.W.: Epstein Barr virus receptors but not viral DNA are present in normal and malignant oral epithelia. J. Oral Pathol. Med. 20:20-25, 1991.
32. Mao E.J., and Smith C.J.: Detection of EBV DNA by the polymerase chain reaction in oral smears from healthy individuals and patients with squamous cell carcinoma. J. Oral Pathol. Med. 22: 12-17, 1993.
33. Salahuddin Z.S., Ablashi D.V., Markham P.D., Joseph S.F., Sturzenegger S., Kaplan M., Halligan G., Biberfeld P., Wong-Stall F., Kramarsky B., and Gallo R.C.: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234: 596-601, 1986.
34. Clark D.A., Alexander F.E., and McKenney P.A.: The seroepidemiology of human herpes virus-6 (HHV-6) from a case control study of leukemia and lymphoma: Int. J. Cancer 45, 829-833, 1990.
35. Shanavas K.R., Kala V., Vasudevan D.M., Vijayakumar T. and Yadav, M.: Anti HHV-6 antibodies in normal population and in cancer patients in India. J.Exp.Pathol. 6: 95-105, 1992.
36. Yadav M., Chandrasekharan A., Vasudevan D.M. and Ablashi D.V.: Frequent detection of human herpes virus-6 in oral carcinoma. J. Natl. Cancer Inst. 86: 1792-1794, 1994.
37. de Villiers E.M.: Heterogeneity of the human papilloma virus group. J. Virol. 63: 4898-4903, 1989.
38. zur Hausen H: Papilloma viruses as carcinoma viruses. Adv. Viral Oncol. 8: 1-26, 1989.
39. Karlsen F., Kristensen G., Holm R., Chitemerere M., Berner A., and Hagmar B.M.: High incidence of HPV in 146 cervical carcinomas; a study using three different pairs of consensus primers, and detecting viral genomes with putative deletions. Europ. J. Cancer 31A: 1511-1516, 1995.
40. Das B.C., Sharma J.K., Gopalkrishna V, Das D.K., Singh V., Gissmann L., zur Hausen H., and Luthra U.K.: A high frequency of human papilloma virus DNA sequences in cervical carcinomas of Indian women as revealed by southern blot hybridisation and polymerase chain reaction. J. Med. Virol. 36: 239-245, 1992.
41. Kjaer S.K., van den Brule A.J., Bock J.E., Poll P.A., Engholm G., Sherman M.E., Walboomers J.M., and Meijer C.J.: Human papilloma virus, the most significant risk determinant of cervical intra epithelial neoplasia. Int. J. Cancer 65: 601-606, 1996.
42. Lopez-Beltran A., Escudero A.L., Vicioso L., Munoz E., and Carrasco J.C.: Human papilloma virus DNA as a factor determining the survival of bladder cancer patients. Br. J. Cancer 73: 124-127, 1996.
43. Jin Y.T., and Toto P.D.: Detection of human papova virus anti-gen in oral papillary lesions. Oral Surg. 58: 702-705, 1984.
44. Ficarra G.: Human papilloma virus and pathology of the oral cavity: Dent.Cadmos. 57: 89-90, 1989.
45. Syrjanen K., Syrjanen S., Lamberg M., Pyrhonen S., and Nuutinen J.: Morphological and immunohistochemical evidences suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int.J.Oral Surg. 12: 418-424, 1983.
46. Eisenburg E., Rosenberg B., Krutchkoff D.J.: Verrucous carcinoma; a possible viral pathogenesis. Oral Surg. 59: 52-57, 1985.
47. de Villers E.M., Weidawr H., Otto H., and zur Hausen H.: Papilloma virus DNA in human tongue carcinomas. Int. J. Cancer 36: 575-578, 1985.
48. Mukhopadhyay D., Chatterjee R., and Chakraborty R.N.: Correlation of mitotic abnormalities and the presence of papilloma virus antigens in squamous cell carcinoma of the oral cavity. Cancer Letters 74: 51-56, 1993.
49. Garlick J.A., Calderon S., Buchner A., and Mitrani-Rosenbaum, S.: Detection of human papilloma virus (HPV) DNA in focal epithelial hyperlasia. J.Oral Pathol.Med. 18: 172-177, 1989.
50. de Villiers E.M., Weidawr H., Otto H., and zur Hausen H.: Papilloma virus DNA in human tongue carcinomas. Int. J. Cancer 36: 575-578, 1985.
51. Milde K., and Loning T.: Detection of HPV DNA in oral papillomas and carcinomas; application of in-situ hybridisation with biotynylated HPV-16 probes. J. Oral Pathol. 15: 292-296, 1986.
52. Maitland N.J., Cox M.F., Lynas C., Prime S.S., Meanwell C.A., and Scully C.: Detection of HPV DNA in biopsies of human oral tissue. Br. J. Cancer 56: 245-250, 1987.
53. Yeudall W.A., and Campo M.S.: Human papilloma virus DNA in biopsies of oral tissues. J. Gen. Virol. 72: 173-176, 1991.
54. Maitland N.J., Bromidge T., Cox M.F., Crane I.J., Prime S.S., and Scully C.: Detection of human papilloma virus genes in human oral tissue biopsies and cultures by polymerise chain reaction. Br. J. Cancer 59: 698-703, 1989.
55. Shanavas K.R., Elyas K.K., Beena C., Vijayakumar T., Mani V, and Vasudevan D.M.: Human papilloma virus antigen and DNA in human oral cancer tissues. Oral Oncol. 3A: 244-247, 1994.
56. Balaram P., Nalinakumari K.R., Abraham E., Balan A., Hareendran N.K., Bernard H.U., and Chan S.Y.: Human papilloma viruses in 91 oral canceres from Indian betal quid chewers, high prevalence and multiplicity of infections: Int. J. Cancer 61: 450-454, 1995.
57. Jeon S., Allen-Hoffman B.L., and Lambert P.F.: Integration of HPV type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69: 2989-2997, 1995.
58. Steenbergen R.D., Hermsen M.A., Walboomers J.M., Joenje H., Arwert F., Meijer C.J., and Snijders P.J.: Integrated human HPV type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivate cell line. Cancer Res. 55: 5465-5471, 1995.
59. Barbosa M.S., Edmonds C., Fisher C., Schiller J.T., Lowy D.R., and Vousden K.H.: The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J. 9: 153-160, 1990.
60. Patrick D.R., Oliff A., and Heimbrook D.C.: Identification of a novel retinoblastoma gene product binding site on human papilloma virus type 16 E7 protein. J. Biol. Chem. 269: 6842-6850, 1994.
61. Mao E.J., Schwartz S.M., Daling J.R., Oda D., Tickman L., and Beckmann A.M.: Human papilloma viruses and p53 mutations in normal premalignant and malignant oral epithelia: Int. J. Cancer 69: 152-158, 1996.
62. Mukhopadhyay D., Chatterjee R., and Chakraborty R.N.: Association of p53 expression with cytokinetics and HPV capsid antigen prevalence in oral carcinomas. Cancer Letters 87: 99-105, 1994.
63. Werness V.A., Levine A.J., and Howley P.M.: Association of human papilloma virus types 16 and 18 E6 proteins with p53. Science 248: 76-79, 1990.
64. Havre P.A., Yuan J., Hedrick L., Cho K.R., and Glazer P.M.: p53 inactivation by HPV-16 E6 results in increased mutagenesis in human cells. Cancer Res. 55: 4420-4424, 1995.
65. Nurnberg W., Artuc M., Vorbrueggen G., Kalkbrenner F., Moelling K., Czametzki B.M., and Schadendorf D.: Nuclear proto-oncogene products transactivate the HPV type 16 promoter. Br. J. Cancer 71: 1018-1024, 1995.
66. Crook T., Fisher C., Masterson P.J., and Vousden K.H.: Modulation of transcriptional regulatory properties of p53 by HPV E6. Oncogene 9: 1225-1230, 1994.
67. Scully C.: Viruses and oral squamous carcinoma. Oral Oncol. Europ. J. Cancer 28B: 57-59, 1992.
68. Chiba I., Shindoh M., Yasuda M., Yamagaki, Y., Amemiya A., Sato Y., Fujinaga K., Notani K., and Fukuda H.: Mutations in the p53 gene and human papilloma virus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 12: 1663-1668, 1996.
69. Park N.H., Gujuluva C.N., Back J.H., Cherrick H.M., Shin K.H., and Min B.M.: Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene; an in vitro multistep carcinogenesis model. Oncogene 10: 2145-2153, 1995.
70. Chang F., Syrjanen S., and Nuutinen J.: Detection of HPV DNA in oral squamous cell carninomas by in-situ hybridisation and polymerase chain reactions. Arch. Dermatol. Res. 282: 493-497, 1990.